Wan Ying, McDaniel Kelly, Wu Nan, Ramos-Lorenzo Sugeily, Glaser Trenton, Venter Julie, Francis Heather, Kennedy Lindsey, Sato Keisaku, Zhou Tianhao, Kyritsi Konstantina, Huang Qiaobing, Annable Tami, Wu Chaodong, Glaser Shannon, Alpini Gianfranco, Meng Fanyin
Division of Research, Central Texas Veterans Healthcare System, Temple, Texas; Baylor Scott & White Health Digestive Disease Research Center, Baylor Scott & White Healthcare, Temple, Texas; Department of Internal Medicine, Texas A&M University Health Science Center College of Medicine, Temple, Texas; Department of Pathophysiology, Southwest Medical University, Luzhou, China.
Division of Research, Central Texas Veterans Healthcare System, Temple, Texas; Baylor Scott & White Health Digestive Disease Research Center, Baylor Scott & White Healthcare, Temple, Texas; Department of Internal Medicine, Texas A&M University Health Science Center College of Medicine, Temple, Texas.
Am J Pathol. 2017 Dec;187(12):2788-2798. doi: 10.1016/j.ajpath.2017.08.027. Epub 2017 Nov 8.
Alcoholic liver disease remains a major cause of liver-related morbidity and mortality, which ranges from alcoholic steatohepatitis to fibrosis/cirrhosis and hepatocellular carcinoma, and the related mechanisms are understood poorly. In this study, we aimed to investigate the role of miR-34a in alcohol-induced cellular senescence and liver fibrosis. We found that hepatic miR-34a expression was upregulated in ethanol-fed mice and heavy drinkers with steatohepatitis compared with respective controls. Mice treated with miR-34a Vivo-Morpholino developed less severe liver fibrosis than wild-type mice after 5 weeks of ethanol feeding. Further mechanism exploration showed that inhibition of miR-34a increased cellular senescence of hepatic stellate cells (HSCs) in ethanol-fed mice, although it decreased senescence in total liver and hepatocytes, which was verified by the changes of senescence-associated β-galactosidase and gene expression. Furthermore, enhanced cellular senescence was observed in liver tissues from steatohepatitis patients compared with healthy controls. In addition, the expression of transforming growth factor-β1, drosophila mothers against decapentaplegic protein 2 (Smad2), and Smad3 was decreased after inhibition of miR-34a in ethanol-fed mice. Our in vitro experiments showed that silencing of miR-34a partially blocked activation of HSCs by lipopolysaccharide and enhanced senescence of HSCs. Furthermore, inhibition of miR-34a decreased lipopolysaccharide-induced fibrotic gene expression in cultured hepatocytes. In conclusion, our data suggest that miR-34a functions as a profibrotic factor that promotes alcohol-induced liver fibrosis by reducing HSC senescence and increasing the senescence of hepatocytes.
酒精性肝病仍然是肝脏相关发病和死亡的主要原因,其范围从酒精性脂肪性肝炎到纤维化/肝硬化和肝细胞癌,而相关机制尚不清楚。在本研究中,我们旨在探讨miR-34a在酒精诱导的细胞衰老和肝纤维化中的作用。我们发现,与各自的对照组相比,乙醇喂养的小鼠和患有脂肪性肝炎的重度饮酒者肝脏中miR-34a的表达上调。用miR-34a Vivo-Morpholino处理的小鼠在乙醇喂养5周后,肝纤维化程度比野生型小鼠轻。进一步的机制探索表明,抑制miR-34a可增加乙醇喂养小鼠肝星状细胞(HSC)的细胞衰老,尽管它可降低全肝和肝细胞的衰老,这通过衰老相关β-半乳糖苷酶和基因表达的变化得到证实。此外,与健康对照相比,脂肪性肝炎患者肝脏组织中观察到细胞衰老增强。此外,在乙醇喂养的小鼠中抑制miR-34a后,转化生长因子-β1、果蝇抗五聚体蛋白2(Smad2)和Smad3的表达降低。我们的体外实验表明,沉默miR-34a可部分阻断脂多糖对HSC的激活,并增强HSC的衰老。此外,抑制miR-34a可降低脂多糖诱导的培养肝细胞中纤维化基因的表达。总之,我们的数据表明,miR-34a作为一种促纤维化因子,通过减少HSC衰老和增加肝细胞衰老来促进酒精性肝纤维化。